Enzastaurin Versus Lomustine in Glioblastoma
Clinical trial NCT00295815 · COMPLETED
Trial details
- NCT number
- NCT00295815
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2007-08-01
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.